DOI:
10.1055/s-00000003
Aktuelle Ernährungsmedizin
LinksClose Window
References
Duggan BM, Foley KP, Henriksbo BD. et al.
Tyrosine kinase inhibitors of Ripk2 attenuate bacterial cell wall-mediated lipolysis, inflammation and dysglycemia.
Scientific reports 2017;
7: 1578
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.